Meet the Editors

Benoît Blondeau, MD MBA FACS is the medical director of the level one trauma center, and Associate Professor of surgery and palliative care at the University of New Mexico in Albuquerque, USA.

A graduate of the school of medicine of the Tours university, in Tours, France (Faculté de Médecine) in general and vascular medicine, he trained in general surgery and organ transplantation in the USA (Howard University, University of Missouri Kansas City, and the Mount Sinai Hospital).

Dr Chinmoy K Bose is a Senior Professor and Head of Clinical Trials in a tertiary cancer centre in India. He serves as an examiner in oncology super speciality, has been involved in ovarian cancer drug development for the last 25 years and is an international peer in the field of ovarian cancer etiology. 

Dr Bose obtained his MD qualification in Obstetrics and Gynaecology from Ramakrishna Mission Seva Prathisthana, Kolkata, India, in 1989. His sub-speciality training, registrarship and PhD (1996) in gynaecological oncology were completed in the Chittaranjan National Cancer Institute, Kolkata. Dr Bose has won Royal Society and DFG fellowships, and received multiple travel grants from AACR, ASCO, etc. His many important publications include book chapters and a book on oncology and endocrinology. 

Dr Bose has been serving as an expert in oncology in drug regulatory authority of the government of India for 10 years. He is an ethics committee member of a cancer hospital and serves as expert in stem cell committee of India government. He had served as executive member in Indian branch (FPAI) of IPPF, UK.

Dr Tibor Fülöp is a Professor of Medicine at the Medical University of South Carolina and current Chief of Nephrology Section at the University-affiliated Ralph H. Johnson VA Medical Center. He is a “summa cum laude” graduate of the Semmelweis University of Budapest, Hungary (M.D. 1990) with a subsequent Ph.D. degree obtained in 2018.. He obtained his postgraduate medical training at the University Iowa in Iowa City, IA and the Henry Ford Hospital in Detroit, MI. He is currently board certified in both Internal Medicine and Nephrology and actively engaged in clinical care, teaching and research. 

Altogether, he authored or co-authored more than 120 peer-reviewed scientific papers and participated in several local and nation-wide epidemiologic cohort studies, including Jackson Heart Study, ARIC, and the CARe initiative and has now ongoing scientific collaborations with investigators at the University of Mississippi, University of Tennessee, Mayo Clinic, Thomas Jefferson University and the Semmelweis University in Hungary. He mentored numerous trainees in the past and regularly presents at both regional and national meetings. 

Dr Fülöp is a Fellow for the American College of Physicians and the American Society of Nephrology both and holds membership in several national and international professional societies. He is serving on the Editorial Board of six Nephrology or Internal Medicine journals and have peer-reviewed for additional >35 journals in the past. His clinical interests include Intensive Care nephrology, home-based renal replacement therapies, medical prevention of kidney stones and renal vasculitis. Dr Fulop is named among the Top Doctors in America (2012-2020 Nephrology).  

Emmanouil I. Kapetanakis M.D., M.Sc. is a specialist oncological thoracic surgeon with a mixed clinical/surgical and academic/research practice specializing in the management of lung cancer and chest malignancies. Having realized the importance for a surgeon to possess a broad oncological opinion and a multidisciplinary management approach he has pursued an oncology concentrated surgical education. Therefore, he has completed postgraduate coursework in Thoracic Oncology at the University of Athens and in Lung Cancer at the University of Zurich, as well as fellowships in minimally invasive thoracic surgery at the Mater Misericordiae University Hospital in Dublin, Ireland and in thoracic surgical oncology at the European Institute of Oncology (I.E.O.) in Milan, Italy.

His research expertise includes both laboratory/bench and clinical/epidemiological research having performed significant research on thoracic surgery, focusing mainly on lung cancer and thoracic oncology. He has a respectable research and academic profile, having published more than 60 papers in reputable medical journals, with quite a high impact factor, while he also has over 60 oral and posted presentations in medical conferences and workshops as well as numerous guest speeches at respective conferences. Dr. Kapetanakis’ has acted as principal investigator and as co-investigator in a number of studies on surgical techniques, thoracic anesthesia and thoracic oncology. He also serves as a reviewer in several reputable scientific journals.

He has held various academic and educational positions, both in Greece and abroad, teaching medical students as well as trainee doctors. Dr. Kapetanakis is a member of a number of Greek and international medical and surgical professional societies and is secretary of the Education Working Group of the Hellenic Society of Thoracic and Cardiovascular Surgeons and a member of the Educational Board of the Hellenic Surgical Society. He is married and has a young son.

Dr Jean Karl Soler is a family doctor, specialist in occupational medicine, and researcher. He has run studies on burnout in European family doctors in collaboration with EGPRN, and on mathematical models of the diagnostic process in primary care in collaboration with the Academic Medical Centre of the University of Amsterdam under the late Prof. Henk Lamberts and Dr. Inge Okkes. 

He has collaborated with the TRANSFoRm project on learning healthcare systems to reduce diagnostic error in primary care under the leadership of Prof. Brendan Delaney at Imperial College, London, and the eHID electronic health indicator database project led by the late Dr. Douglas Fleming. 

Dr Soler leads the research arm of the Mediterranean Institute of Primary Care, and organises continuing medical education for the Malta College of Family Doctors. He is also the Maltese representative for the European General Practice Research Network, and is a long-standing member of the Wonca International Classification Committee with a role in maintaining the International Classification of Primary Care. He has 34 indexed publications, and has read for his PhD degree at the University of Ulster, Northern Ireland. He is also very active in historical re-enactments of Malta’s role in the Second World War.

Dr Elie G. Dib, MD, FACP is the Associate Director for the Medical Oncology-Hematology Fellowship program at St Joseph Mercy Hospital in Ann Arbor, Michigan and the Deputy-Principal Investigator for the NCI Community Oncology Research Program (NCORP) at the Michigan Cancer Research Consortium. He is a Harvard Alumni in Cancer Biology and Therapeutics Postgraduate Medical Program and his clinical interest are in Immuno-Oncology and Immuno-Genomics as well as Malignant Hematological diseases. 

Dr Dib serves as the vice-chair for the Immuno-Oncology Committee at the Alliance for Clinical Trials in Oncology. He has expertise as Deputy-Editor for JMCR and in peer-review process for several medical journals and has peer reviewed ABIM educational modules for several consecutive years.  He serves as an Associate Editor for ASCO-SEP. He also serves on the ASCO Educational Book expert panel as well as ASCO eLearning and In-Training Exam Item Writing Committee. He served as course director for the Society for Immunotherapy of Cancer (SITC).